, Singapore
1173 views
/Pixabay

Manulife SG unveils two industry-first collaboration for cancer care, gut health

It will offer liquid biopsy for cancer care and gut health screening.

Manulife Singapore partnered with precision oncology company Guardant Health to provide eligible customers with access to the Guardant360 liquid biopsy test. It also partnered with AMILI, Southeast Asia's first gut microbiome insights company, to offer eligible customers access to advanced gut microbiome screening.

The initiative aims to support personalised cancer treatments for customers with advanced solid tumour cancers, potentially improving clinical outcomes.

The Guardant360 test offers comprehensive genomic profiling for all advanced solid cancers, identifying guideline-recommended biomarkers through a simple blood draw. 

Results are available within seven days after the sample is received, addressing gaps for patients who lack sufficient tumour tissue for standard biopsies. 

Its partnership with AMILI marks the first time such technology is available through a life insurer in Singapore.

The screening analyses the trillions of bacteria in an individual's gut, providing personalised insights to improve immunity, brain health, and nutrition.

These insights aim to help prevent lifestyle diseases and support overall well-being. Details on eligibility and redemption will be announced later.

AMILI’s test leverages the region's largest multi-ethnic Asian gut microbiome database to deliver precise insights tailored to the Asian population. 

Customers will receive a complimentary session with AMILI physicians to interpret their results and adopt a holistic approach to improving their health.
 

Follow the link s for more news on

Join Singapore Business Review community
A NOTE FROM SINGAPORE BUSINESS REVIEW

If you've been wondering whether SBR could work for your company — yes, probably.

A lot of the companies we partner with started as readers. They'd been following our coverage for a while, saw their own customers and competitors in it, and eventually asked the obvious question: could we do something with you? The answer is usually yes. The shape of it depends on what you're trying to do.


The options are broader than most people assume — thought leadership articles, sponsored content, industry summits across Southeast Asia, regional awards programmes, podcasts, and media placements in print and digital. Some partners use one channel; most use a mix. We figure out the right combination by starting with your brief, not with our rate card.


So if the question has been on your mind, here's the easy way to ask it.

We'll tell you honestly whether we can help, and how. It's a better use of everyone's time.